Ordering
| Item | Catalog # | Description | Quantity | Price (USD) | ||
|---|---|---|---|---|---|---|
| Plasmid | 100835 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $75 | Add to Cart | |
| AAV1 | 100835-AAV1 | Virus (100 µL at titer ≥ 1×10¹³ vg/mL)and Plasmid.More Information | Add to Cart | |||
| AAV5 | 100835-AAV5 | Virus (100 µL at titer ≥ 7×10¹² vg/mL)and Plasmid.More Information | Add to Cart | |||
| AAV9 | 100835-AAV9 | Virus (100 µL at titer ≥ 1×10¹³ vg/mL)and Plasmid.More Information | Add to Cart | |||
This material is available to academics and nonprofits only.
Backbone
- Vector backbonepAAV(Search Vector Database)
- Vector typeMammalian Expression, AAV
Growth in Bacteria
- Bacterial Resistance(s)Ampicillin
- Growth Temperature37°C
- Growth Strain(s)NEB Stable
- Copy numberUnknown
Gene/Insert
- Gene/Insert nameGCaMP6f
- Alt nameGCaMP3 variant 693
- SpeciesSynthetic
- Insert Size (bp)1353
- MutationGCaMP3-T302L R303P A317E D380Y T381R S383T R392G
- PromoterCAG
Cloning Information
- Cloning methodUnknown
- 5′ sequencing primerunknown (Common Sequencing Primers)
Resource Information
- Supplemental Documents
- pAAV.CAG.Flex.GCaMP6f.WPRE.SV40 (p2816)_Q.gb
- Terms and Licenses
- UBMTA
- genOway Notice of RIghts
- Industry Terms
- Not Available to Industry
- Articles Citing this Plasmid
- 2 References
Depositor Comments
This plasmid was previously available as pAAV.CAG.Flex.GCaMP6f.WPRE.SV40 (p2816) from the Penn Vector Core. This plasmid was created as part of the GENIE project at Janelia Research Campus.
Information for AAV1 (Catalog # 100835-AAV1)(Back to top)
Purpose
Ready-to-use AAV1 particles produced from pAAV.CAG.Flex.GCaMP6f.WPRE.SV40 (#100835). In addition to the viral particles, you will also receive purified pAAV.CAG.Flex.GCaMP6f.WPRE.SV40 plasmid DNA.
CAG-driven, Cre-dependent GCaMP6f calcium sensor. These AAV preparations are suitable purity for injection into animals.Delivery
- Volume100 µL
- Titer≥ 1×10¹³ vg/mL
- Pricing$350 USD for preparation of 100 µL virus + $30 USD for plasmid.
- StorageStore at -80℃. Thaw just before use and keep on ice.
- ShipmentViral particles are shipped frozen on dry ice. Plasmid DNA (≥ 200ng) will also be included in the shipment.
Viral Production & Use
- Packaging Plasmidsencode adenoviral helper sequences and AAV rep gene, AAV1 cap gene
- BufferPBS + 0.001% Pluronic F-68
- SerotypeAAV1
- PurificationIodixanol gradient ultracentrifugation
Biosafety
Requestor is responsible for compliance withtheir institution"s biosafety regulations.Lentivirus is generally considered BSL-2. AAV isgenerally considered BSL-1, but may requireBSL-2 handling depending on the insert.Biosafety Guide
Resource Information
- Terms and Licenses
- Ancillary Agreement for Penn Vectors
- Terms of Use for Viral Vectors
- Industry Terms
- Not Available to Industry
Viral Quality Control
- Addgene ensures high quality viral vectors by optimizing and standardizing production protocols and performing rigorous quality control (QC) (see a list of our QC assays). Thespecific QC assays performed varies for each viral lot. To learn which specific QC assays were performed on your lot, please contact us.
- Titer: the exact titer of your sample will be reported on the tube. The titer you see listed on this page is the guaranteed minimum titer. See how titers are measured.
Visit our viral production page for moreinformation.
Addgene Comments
Using FLEX vectors in vivo: LoxP sites in FLEX plasmids are known to recombine during DNA amplification and viral vector production, which may result in a minority of Cre-activated (i.e., "flipped") viral vectors. Addgene has measured this occurs in 0.01-0.03% of viral vectors in our typical production protocol. This can lead to a small number of cells exhibiting Cre-independent transgene expression in vivo. To address this, we recommend titrating to find the optimal AAV dosage required for Cre-dependent transgene expression and function in vivo. This may include reducing the viral vector dosage in order to reduce the likelihood of Cre-independent expression.
Information for AAV5 (Catalog # 100835-AAV5)(Back to top)
Purpose
Ready-to-use AAV5 particles produced from pAAV.CAG.Flex.GCaMP6f.WPRE.SV40 (#100835). In addition to the viral particles, you will also receive purified pAAV.CAG.Flex.GCaMP6f.WPRE.SV40 plasmid DNA.
CAG-driven, Cre-dependent GCaMP6f calcium sensor. These AAV preparations are suitable purity for injection into animals.Delivery
- Volume100 µL
- Titer≥ 7×10¹² vg/mL
- Pricing$350 USD for preparation of 100 µL virus + $30 USD for plasmid.
- StorageStore at -80℃. Thaw just before use and keep on ice.
- ShipmentViral particles are shipped frozen on dry ice. Plasmid DNA (≥ 200ng) will also be included in the shipment.
Viral Production & Use
- Packaging Plasmidsencode adenoviral helper sequences and AAV rep gene, AAV5 cap gene
- BufferPBS + 0.001% Pluronic F-68
- SerotypeAAV5
- PurificationIodixanol gradient ultracentrifugation
Biosafety
Requestor is responsible for compliance withtheir institution"s biosafety regulations.Lentivirus is generally considered BSL-2. AAV isgenerally considered BSL-1, but may requireBSL-2 handling depending on the insert.Biosafety Guide
Resource Information
- Terms and Licenses
- Terms of Use for Viral Vectors
- Industry Terms
- Not Available to Industry
Viral Quality Control
- Addgene ensures high quality viral vectors by optimizing and standardizing production protocols and performing rigorous quality control (QC) (see a list of our QC assays). Thespecific QC assays performed varies for each viral lot. To learn which specific QC assays were performed on your lot, please contact us.
- Titer: the exact titer of your sample will be reported on the tube. The titer you see listed on this page is the guaranteed minimum titer. See how titers are measured.
Visit our viral production page for moreinformation.
Addgene Comments
Using FLEX vectors in vivo: LoxP sites in FLEX plasmids are known to recombine during DNA amplification and viral vector production, which may result in a minority of Cre-activated (i.e., "flipped") viral vectors. Addgene has measured this occurs in 0.01-0.03% of viral vectors in our typical production protocol. This can lead to a small number of cells exhibiting Cre-independent transgene expression in vivo. To address this, we recommend titrating to find the optimal AAV dosage required for Cre-dependent transgene expression and function in vivo. This may include reducing the viral vector dosage in order to reduce the likelihood of Cre-independent expression.
Information for AAV9 (Catalog # 100835-AAV9)(Back to top)
Purpose
Ready-to-use AAV9 particles produced from pAAV.CAG.Flex.GCaMP6f.WPRE.SV40 (#100835). In addition to the viral particles, you will also receive purified pAAV.CAG.Flex.GCaMP6f.WPRE.SV40 plasmid DNA.
CAG-driven, Cre-dependent GCaMP6f calcium sensor. These AAV preparations are suitable purity for injection into animals.Delivery
- Volume100 µL
- Titer≥ 1×10¹³ vg/mL
- Pricing$350 USD for preparation of 100 µL virus + $30 USD for plasmid.
- StorageStore at -80℃. Thaw just before use and keep on ice.
- ShipmentViral particles are shipped frozen on dry ice. Plasmid DNA (≥ 200ng) will also be included in the shipment.
Viral Production & Use
- Packaging Plasmidsencode adenoviral helper sequences and AAV rep gene, AAV9 cap gene
- BufferPBS + 0.001% Pluronic F-68
- SerotypeAAV9
- PurificationIodixanol gradient ultracentrifugation
Biosafety
Requestor is responsible for compliance withtheir institution"s biosafety regulations.Lentivirus is generally considered BSL-2. AAV isgenerally considered BSL-1, but may requireBSL-2 handling depending on the insert.Biosafety Guide
Resource Information
- Terms and Licenses
- Ancillary Agreement for Penn Vectors
- Terms of Use for Viral Vectors
- Industry Terms
- Not Available to Industry
Viral Quality Control
- Addgene ensures high quality viral vectors by optimizing and standardizing production protocols and performing rigorous quality control (QC) (see a list of our QC assays). Thespecific QC assays performed varies for each viral lot. To learn which specific QC assays were performed on your lot, please contact us.
- Titer: the exact titer of your sample will be reported on the tube. The titer you see listed on this page is the guaranteed minimum titer. See how titers are measured.
Visit our viral production page for moreinformation.
Addgene Comments
Using FLEX vectors in vivo: LoxP sites in FLEX plasmids are known to recombine during DNA amplification and viral vector production, which may result in a minority of Cre-activated (i.e., "flipped") viral vectors. Addgene has measured this occurs in 0.01-0.03% of viral vectors in our typical production protocol. This can lead to a small number of cells exhibiting Cre-independent transgene expression in vivo. To address this, we recommend titrating to find the optimal AAV dosage required for Cre-dependent transgene expression and function in vivo. This may include reducing the viral vector dosage in order to reduce the likelihood of Cre-independent expression.
ebiomall.com
>
>
>
>
>
>
>
>
>
>
>
>
描述物质分子对辐射吸收的程度随波长而变的函数关系曲线，称为吸收光谱或吸收曲线。紫外-可见吸收光谱通常由一个或几个宽吸收谱带组成。最大吸收波长（λmax）表示物质对辐射的特征吸收或选择吸收，它与分子中外层电子或价电子的结构（或成键、非键和反键电子）有关。朗伯-比尔定律是分光光度法和比色法的基础。这个定律表示：当一束具有I0强度的单色辐射照射到吸收层厚度为b，浓度为c的吸光物质时，辐射能的吸收依赖于该物质的浓度与吸收层的厚度。其数学表达式为： 式中的A叫做吸光度；I0为入射辐射强度；I为透过吸收层的辐射强度；（I／I0）称紫藤为透射率T；ε是一个常数，叫做摩尔吸光系数，ε值愈大，分光光度法测定的灵敏度愈高。
紫外-可见分光光度计由5个部件组成：①辐射源。必须具有稳定的、有足够输出功率的、能提供仪器使用波段的连续光谱，如钨灯、卤钨灯（波长范围350～2500纳米），氘灯或氢灯（180～460纳米），或可调谐染料激光光源等。②单色器[1]。它由入射、出射狭缝、透镜系统和色散元件（棱镜或光栅）组成，是用以产生高纯度单色光束的装置，其功能包括将光源产生的复合光分解为单色光和分出所需的单色光束。③试样容器，又称吸收池。供盛放试液进行吸光度测量之用，分为石英池和玻璃池两种，前者适用于紫外到可见区，后者只适用于可见区。容器的光程一般为0.5～10厘米。④检测器，又称光电转换器。常用的有光电管或光电倍增管，后者较前者更灵敏，特别适用于检测较弱的辐射。近年来还使用光导摄像管或光电二极管矩阵作检测器，具有快速扫描的特点。⑤显示装置。这部分装置发展较快。较高级的光度计，常备有微处理机、荧光屏显示和记录仪等，可将图谱、数据和操作条件都显示出来。
仪器类型则有：单波长单光束直读式分光光度计，单波长双光束自动记录式分光光度计和双波长双光束分光光度计。
应用范围包括：①定量分析，广泛用于各种物料中微量、超微量和常量的无机和有机物质的测定。②定性和结构分析，紫外吸收光谱还可用于推断空间阻碍效应、氢键的强度、互变异构、几何异构现象等。③反应动力学研究，即研究反应物浓度随时间而变化的函数关系，测定反应速度和反应级数，探讨反应机理。④研究溶液平衡，如测定络合物的组成，稳定常数、酸碱离解常数等。
荧光分析法 利用某些物质被紫外光照射后所发生的能反映出该物质特性的荧光，
可以进行定性或定量分析的方法。
特点：灵敏度更高 10-10-10-12g/ml，应用不如UV广泛。
应用：①直接荧光光度法
②作为HPLC的检测器（用的多）展开
为充分发挥实验室和仪器设备的使用效益，同时，又保证试验的正常进行和仪器设备的完好率，如果你对实验室管理有任何好的建议，欢迎参与讨论，请不要吝啬你的语言，大家可以从以下话题发表一下自己的看法，谈谈你们实验室是如何进行管理的：
1，试验仪器如何使用和维护；
2，试验卫生如何进行清洁与维护；
3，实验室安全问题；
........
格式不限，有一计说一计，请不要在网上搜一堆相关的资料发帖参与讨论，更希望能看到你在实际管理中的经验交谈；
有疑问就有解答，同时也欢迎你提出你的疑问，期待你的参与！
但是因为荧光剂是一种会溶于液体并随之迁移又很难去除的化学物质，所以一旦洗衣液中的荧光剂附着在衣物上，用洗衣机大力清洗，也不用担心被洗掉，对人的皮肤和身体都有害，所以选择不含荧光剂的衣衣不舍洗衣宝是必要的。
荧光增白剂其实是一种荧光染料，或者说是种白色染料，它的特性是能激发入射光线产生荧光，使所染物质获得类似荧石的闪闪发光的效应，使肉眼看到的物质很白，达到增白的效果。
从国家质监局网站了解到，纺织、造纸、洗涤剂等产品中，国家是允许使用荧光增白剂，但荧光剂的使用并非没有禁忌，我国食品卫生法第六条明确规定，食品、食品包装、餐巾纸禁止使用荧光增白剂。
荧光剂对人体的危害目前国内还没有定论，也没有具体证据证明荧光剂吸收多少才会对人体造成伤害，但是在国外，荧光增白剂确实被列为潜在致癌物质之一。
为了帮助丁香园的兄弟姐妹申请到2007年国家自然科学基金，本人联合老婆继成功申请到2005年的国基之后，再次在10月份飞来捷报，又中了2006年的国基。不是本人牛气，首先要感谢从丁香园学到的“独家秘笈”的成功应用。为了感谢丁香园，本人和老婆呕血力创，推出我们申请国基的几大秘诀，提供给2007年奋斗的人们。
今天介绍第一计，审时度势。
所谓审时度势，关键在于要搞清楚基金究竟要赞助那些人，一般来说，国家设立基金，目的就是赞助那些能够在科研上有突破的人
。判断那些人能够在科研上有突破，这个就依靠评委来判断了，要知道国基从来不会雪中送炭，只会锦上添花。
你要申请，首先要想，假如你是评委，你写的这封标书送到你手上了，让你来判断是不是会有突破性成果，你怎样来判断？
你肯定说看工作基础，对了，这几乎是肯定的。就是一个申请青年基金的人，尽管不是很强调工作基础，但你想，现在评委的手里绝对不是就你一个基金标书，现在哪个角落、那个地方，可以说只要是人都在想办法申请基金，标书多的吓死人。评委不可能看到是青年基金，就不看工作基础了。所以不要认为申请青年基金，就可以不在工作基础上下功夫了。
那么，问题来了，如何在工作基础的书写上下功夫？或者说如何让评委一看就知道你是有工作基础的人？
当然是你发表的文章了，如果你在nature上发表一篇文章，兄弟，你不光今年可以中，明年也有你的份，而且，你申请20万，人家会说20万怎么会够？给40万吧。
一般来说，只要你能够在你从事的领域10％最高影响力上发表过一两篇文章，在工作基础方面你就不用愁了。现在的国内学者非常看重SCI的影响因子，因此呢，是人就知道这说明你在科研方面能够有突破。
因此工作基础最重要的是你有牛B文章，而不在于你发表文章的多少。从这个意义上来说，很多中文文章都是～～，呵呵，那个词太难听，不说了。
因此呀，奔2007国基的兄弟们，第一件要做的事情就是埋头工作，搞上几年，来一篇牛文。这是最重要的。
如果没有牛文，就拉那些有牛文的人入股，呵呵，这也应该算工作基础。有人说了，我真的没有，但还想申请，哪怎么办？兄弟不要急，请看第二计，瞒天过海。
